Jeniffer Dantas Ferreira

Jeniffer Dantas Ferreira

Auto-generated profile, based on publicly available information

Jeniffer Dantas Ferreira

Universidade Federal do Acre – Rio Branco (AC), Brasil

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Ciencia & Saude Coletiva
Verified
Journal Article
Open access
TSTainá Bastos dos Santos
Tainá Bastos dos Santos
ABAnne Karin da Mota Borges
Anne Karin da Mota Borges
JFJeniffer Dantas Ferreira
Jeniffer Dantas Ferreira
KMKarina Cardoso Meira
Karina Cardoso Meira
MSMirian Carvalho de Souza
Mirian Carvalho de Souza
RJRafael Tavares Jomar
Rafael Tavares Jomar
Resumo Este estudo transversal investigou a prevalência e os fatores associados ao diagnóstico de câncer de mama em estágio avançado entre 18.890 mulheres assistidas em hospital especializado da capital do Rio de Janeiro, Brasil, entre os anos 1999 e 2016. Utilizou-se regressão de Poisson com variância robusta para estimar razões de prevalência e respectivos intervalos de 95% de confiança. Apresentaram maiores prevalências de diagnóstico nessa condição mulheres com idade entre 20-39 e 40-49 anos, de raça/cor da pele preta e parda, que viviam sem companheiro(a), procedentes de outros municípios do estado do Rio de Janeiro, que tiveram o Sistema Único de Saúde como origem do encaminhamento e que foram diagnosticadas nos sexênios 1999-2004 e 2005-2010. Em contrapartida, mulheres com idade entre 60-69 e 70-99 anos, que cursaram algum nível de escolaridade, com histórico familiar de câncer e que chegaram ao hospital com diagnóstico e sem tratamento apresentaram menores prevalências de diagnóstico em estágio avançado. Esses resultados podem ser considerados no planejamento de ações de prevenção secundária, a fim de antecipar o diagnóstico de câncer de mama dos grupos mais vulneráveis e assim colaborar para a redução da prevalência do diagnóstico em estágio avançado.

22 November 2023 in Hematology, Transfusion and Cell Therapy
Verified
Journal Article
Open access
TMTiago Henrique Monteiro
Tiago Henrique Monteiro
ÍFÍtalo de Jesus da Rocha Ferreira
Ítalo de Jesus da Rocha Ferreira
AJAntonio Carlos Fonseca Pontes Junior
Antonio Carlos Fonseca Pontes Junior
HCHumberto Sanches Chocair
Humberto Sanches Chocair
JFJeniffer Dantas Ferreira
Jeniffer Dantas Ferreira
It has been estimated that the proportion of blood donors in Brazil is below 2.0 %, lower than that recommended by the World Health Organization, which is between 3 % and 5 % of the population. The aim of this study was to analyze the factors that can influence blood donation. This is an integrative review, whose bibliographic search was carried out through the Virtual Health Library, considering scientific articles indexed in the Latin American and Caribbean Literature in the Health Sciences database. This process was performed in July 2022 with term "blood donors" and 901 publications were identified, without delimitation of the study period or any other aspects. After applying the inclusion and exclusion criteria, 40 articles were fully reviewed. The studies were categorized according to the main content discussed in "characteristics and perspectives of donors", "perspective of health professionals and services" and "loyalty strategies: marketing and communication in health". Access to coherent information about the donation process was the motivational aspect evidenced in the three categories of analysis, that is, indispensable from the perspective of users, health professionals who work in blood therapy services and for marketing and communication in health. It is through the knowledge of the procedure that uncertainties and fear are decreased and loyal donors are increased. Altruism was the most frequent driving feeling in the consulted literature, whereas the lack of time and fear were the routine obstacles. The campaigns were identified as communication and health education actions relevant to attracting and retaining the donor, as well as applications and social networks.

1 May 2015 in European Journal Of Cancer Prevention
Verified
Journal Article
Closed access
ACArnaldo C. Couto
Arnaldo C. Couto
JFJeniffer D. Ferreira
Jeniffer D. Ferreira
MPMaria S. Pombo-De-Oliveira
Maria S. Pombo-De-Oliveira
SKSérgio Koifman
Sérgio Koifman
Childhood leukemia etiology, and mainly the interactions of genetic and environmental risk factors, remains largely unexplored. This national hospital-based case-control study was carried out in Brazil among children aged 0-23 months who were recruited at cancer and general hospitals in 13 states. Maternal medicine intake during pregnancy, including analgesic intake, was assessed by face-to-face interviews with the mothers of 231 leukemia patients and 411 controls. Unconditional logistic regression was used to ascertain crude and adjusted odds ratios (ORs), and their 95% confidence intervals (CIs) for the association between maternal analgesic use during pregnancy and early age leukemia. Acetaminophen use during the first trimester of pregnancy showed an OR=0.39 (95% CI 0.17-0.93) for acute lymphocytic leukemia and an OR=0.37 (95% CI 0.16-0.88) for use in the second trimester. For acute myeloid leukemia, an OR=0.11 (95% CI 0.02-0.97) was found following acetaminophen use in the second trimester. For acute lymphocytic leukemia, the exclusive use of dipyrone during preconception showed an OR=1.63 (95% CI 1.06-2.53) and dipyrone intake during lactation showed an OR=2.00 (95% CI 1.18-3.39). These results suggest that acetaminophen use during pregnancy may protect against development of early age leukemia in the offspring, whereas dipyrone use may act as a risk factor for such an outcome.

10 December 2019 in Revista de Saúde Pública
Verified
Journal Article
Open access
ABAnne Karin Da Mota Borges
Anne Karin Da Mota Borges
JFJeniffer Dantas Ferreira
Jeniffer Dantas Ferreira
SKSergio Koifman
Sergio Koifman
RKRosalina Jorge Koifman
Rosalina Jorge Koifman
BACKGROUND: Although the prognosis of differentiated thyroid carcinoma (DTC) therapy is considered excellent over time, some cases have a poorer prognosis and evolve into death. OBJECTIVE: This study aimed to estimate the 5-year specific survival and to identify prognosis factors in a cohort of DTC adult subjects. METHODS: Survival probability was estimated by Kaplan-Meier's method in a retrospective hospital-based cohort study. Comparisons were made by log-rank test. Prognosis factors were identified using Cox risk modeling and crude and adjusted Hazard Ratio measures were obtained. Two models were estimated, considering age grouping of the 7th and 8th editions of TNM. RESULTS: Specific 5-year survival in the cohort was 98.5% (95%CI: 94.2 - 97.5). Considering TNM 7th edition, the risk estimates were 9.88 (95%CI: 1.67 - 58.33) for age group >= 55 years, 18.87 (95%CI: 7.38 - 48.29) for individuals with distant metastasis, 6.36 (95%CI: 2.26 - 17.91) for patients who underwent lymphadenectomy and 0.16 (95%CI: 0.06 - 0.43) for those who received radioiodine therapy. For TNM 8th edition, the risk estimates were 10.12 (95%CI: 2.05 - 50.09) for age group >= 55 years, 12.43 (95%CI: 4.58 - 33.77) for individuals with distant metastasis, 5.06 (95%CI: 1.82 - 14.05) for patients who underwent lymphadenectomy and 0.19 (95%CI: 0.07 - 0.51) for those who received radioiodine therapy. CONCLUSIONS: This cohort had a very high survival over a 5-year period. The prognosis was negatively influenced by age, distant metastasis and lymphadenectomy, whereas radioiodine therapy was found to be protective.

1 March 2013 in European Journal Of Cancer Prevention
Verified
Journal Article
Closed access
PDF file
ACArnaldo C. Couto
Arnaldo C. Couto
JFJeniffer D. Ferreira
Jeniffer D. Ferreira
SKSérgio Koifman
Sérgio Koifman
MPMaria S. Pombo-De-Oliveira
Maria S. Pombo-De-Oliveira
The objective of this study was to determine the contribution of a familial history of cancer (FHC) to the development of leukemia in children below 2 years of age. This is a national hospital-based case–control study of children 0–24 months of age recruited from 15 Brazilian hospitals from several regions providing oncological care and local general hospitals. Participants’ FHC antecedents were obtained through face-to-face interviews with the mothers of cases and controls using a standardized questionnaire. Unconditional logistic regression was used to determine crude and adjusted (adj.) odds ratios (OR), and the respective 95% confidence intervals (CI), of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) after adjustment for selected variables. FHC antecedents were obtained from 178 ALL, 51 AML, and 428 controls. FHC in second-degree relatives (grandparents, uncles, cousins) showed an adj. OR=1.66 (95% CI 1.12–2.45) for ALL. Antecedents of two or more relatives with cancer showed a statistically significant two-fold higher risk of either ALL or AML. Paternal, and joint paternal and maternal antecedents of cancer also showed statistically significant higher adj. OR, respectively: 1.80 and 1.89 for ALL, and 2.34 and 3.23 for AML. Hematological malignancies among second-degree relatives showed an adj. OR=3.48 (95% CI 1.72–7.09) for ALL. According to the anatomic site, antecedents of leukemia/lymphoma among case relatives, compared with the control ones, showed an OR=2.98 (95% CI 1.52–5.82) for ALL, whereas stomach cancer antecedents showed an OR=3.55 (95% CI 1.02–12.39) for AML. The observed results support the hypothesis that FHC antecedents are associated with leukemogenesis in children below 2 years of age.

1 January 2024 in Amazônia Science and Health
Verified
Journal Article
Open access
PDF file
MAMelissa Moreno de Andrade
Melissa Moreno de Andrade
IOIsis Nara Alves de Oliveira
Isis Nara Alves de Oliveira
JFJeniffer Dantas Ferreira
Jeniffer Dantas Ferreira
TRThainá Souza Ribeiro
Thainá Souza Ribeiro
Aims: To analyze the trend in polio vaccination coverage in the state, health regions and municipalities in Acre. Method: Ecological study, with a quantitative approach, from secondary data of National Immunization Program Information System. Vaccination coverage in children under five years old between 2013 and 2022 was included. Joinpoint was used for trend analysis, estimating the annual percentage change (APC), average change (AAPC) and confidence intervals (95%CI). Results: Vaccination coverage for children under one year of age was higher in Alto Acre. In Rodrigues Alves (AAPC: -11.95 95%CI 16.99; -6.56), Plácido de Castro (AAPC: -10.95 95%CI -20.39;-0.08) and Bujari (APC: - 26.85 95%CI -56.33;-5.34) a significant downward trend was identified. Jordão (AAPC: 2.07 95%CI -1.88;6.11) and Sena Madureira (AAPC: 6.04 95% CI 2.46;9.67) showed an upward trend. The 1st booster had the lowest coverage rate in Acre and health regions. A stationary trend was observed in the state for the 2nd reinforcement and an upward trend in 13 of the 22 municipalities. Conclusion: A decreasing trend was observed for children under one year of age and in the first booster vaccination coverage against Polio in Acre and health regions between 2013 and 2022, similar to other locations in the country. Keywords: Vaccination. Poliovirus Vaccines. Poliomyelitis. Ecological Studies. Nursing. Objetivo: Analisar o comportamento da tendência das coberturas vacinais de poliomielite do estado, regiões de saúde e municípios acreanos. Método: Estudo ecológico, de abordagem quantitativa, oriundo de dados secundários do Sistema de Informação do Programa Nacional de Imunizações. Foram incluídas as coberturas vacinais em crianças menores de cinco anos entre 2013 e 2022. Para a análise de tendência foi utilizado o Joinpoint, estimando a variação percentual anual (APC), a variação média (AAPC) e intervalos de confiança (IC95%). Resultados: No período estudado, a cobertura vacinal para menores de um ano foi maior no Alto Acre. Em Rodrigues Alves (AAPC: -11,95 IC95%16,99; -6,56), Plácido de Castro (AAPC: -10,95 IC95%-20,39;-0,08) e Bujari (APC: -26,85 IC95% -56,33;-5,34) identificou-se tendência de queda significativa. Jordão (AAPC: 2,07 IC95% -1,88;6,11) e Sena Madureira (AAPC: 6,04 IC95% 2,46;9,67) apresentaram tendência ascendente. O 1° reforço apresentou a menor taxa de cobertura no Acre e regiões de saúde. Tendência estacionária foi observada no estado para o 2° reforço e ascendente em 13 dos 22 municípios. Conclusão: Observou-se tendência decrescente para menores de um ano e no 1º reforço da cobertura vacinal contra a Poliomielite no Acre e regiões de saúde entre 2013 e 2022, semelhante a outras localidades no país. Palavras-chave: Vacinação. Vacina contra Poliovírus. Poliomielite. Estudos ecológicos. Enfermagem.